Article Details

Pfizer backs protein degrader drugs with Arvinas deal

Retrieved on: 2021-07-30 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

Pfizer backs protein degrader drugs with Arvinas deal. View article details on hiswai:

Excerpt

$1bn investment to commercialise breast cancer treatment. Pfizer is investing $1 billion (£716 million) in Yale University spin-out Arvinas to ...

Article found on: www.chemistryworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up